| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eddecdb706494124677044d6db7a88b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5e06bbf2a93ce8414011cb5ba011faf8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-318 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-9767
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-15 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-00 |
| filingDate |
2010-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93baf9d984a2241fed2d40e75d71476f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc5ea5dcc361c4507f061a98c1c45207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_47426b8f1f04b66fa7c78b47d9a33ec1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6920c9ea94bf21b903382dc0744ae0de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ee12b0d3dc88020f16881ee995cdff1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ae48c1d85a4c99637a3fd030d4f279
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccb0a3eab7ccea21e8eb4d51c630dec9 |
| publicationDate |
2012-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20120077889-A |
| titleOfInvention |
Atopic dermatitis prevention or treatment composition comprising the extract of pine needles or pine needles as an active ingredient |
| abstract |
The present invention relates to a pharmaceutical composition for the prevention or treatment of atopic dermatitis comprising the extract of pine needles or pine needles as an active ingredient. Extracts of pine needles or pine needles of the present invention are released from macrophages of NO (Nitric Oxide), TNF-α (tumor necrosis factor-α), IL-6 (InterLeukin-6) and IL-1β (Interleukin-1 β) cytokine To reduce inflammation, effectively improve symptoms of atopic dermatitis, such as edema and erosion in mice with atopic dermatitis, and reduce secretion of cytokines and IgE (Immunoglobulin E) antibodies such as IL-4 (InterLeukin-4) It can be usefully used for the prevention or treatment of atopic dermatitis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20190088758-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200022984-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200022987-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160121696-A |
| priorityDate |
2010-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |